Tramm, Trine Kyndi, Marianne Sørensen, Flemming B. Overgaard, Jens Alsner, Jan Influence of intra-tumoral heterogeneity on the evaluation of BCL2, E-cadherin, EGFR, EMMPRIN, and Ki-67 expression in tissue microarrays from breast cancer <p><b>Introduction:</b> The influence of intra-tumoral heterogeneity on the evaluation of immunohistochemical (IHC) biomarker expression may affect the analytical validity of new biomarkers substantially and hence compromise the clinical utility. The aim of this study was to examine the influence of intra-tumoral heterogeneity as well as inter-observer variability on the evaluation of various IHC markers with potential prognostic impact in breast cancer (BCL2, E-cadherin, EGFR, EMMPRIN and Ki-67).</p> <p><b>Material and methods:</b> From each of 27 breast cancer patients, two tumor-containing paraffin blocks were chosen. Intra-tumoral heterogeneity was evaluated (1) within a single tumor-containing paraffin block (‘intra-block agreement’) by comparing information from a central, a peripheral tissue microarray (TMA) core and a whole slide section (WS), (2) between two different tumor-containing blocks from the same primary tumor (‘inter-block agreement’) by comparing information from TMA cores (central/peripheral) and WS. IHC markers on WS and TMA cores were evaluated by two observers independently, and agreements were estimated by Kappa statistics.</p> <p><b>Results:</b> For BCL2, E-cadherin and EGFR, an almost perfect intra- and inter-block agreement was found. EMMPRIN and Ki-67 showed a more heterogeneous expression with moderate to substantial intra-block agreements. For both stainings, there was a moderate inter-block agreement that improved slightly for EMMPRIN, when using WS instead of TMA cores. Inter-observer agreements were found to be almost perfect for BCL2, E-cadherin and EGFR (WS: κ > 0.82, TMAs: κ > 0.90), substantial for EMMPRIN (κ > 0.63), but only fair to moderate for Ki-67 (WS: κ = 0.54, TMAs: κ = 0.33).</p> <p><b>Conclusions:</b> BCL2, E-cadherin and EGFR were found to be homogeneously expressed, whereas EMMPRIN and Ki-67 showed a more pronounced degree of intra-tumoral heterogeneity. The results emphasize the importance of securing the analytical validity of new biomarkers by examining the intra-tumoral heterogeneity of immunohistochemical stainings applied to TMA cores individually in each type of cancer.</p> WS;Ki -67;27 breast cancer patients;IHC markers;inter-block agreement;E-cadherin;evaluation;intra-tumoral heterogeneity;BCL;Ki -67 expression;EMMPRIN;tumor-containing paraffin blocks;EGFR;breast cancer Introduction;TMA cores;biomarker 2017-12-05
    https://tandf.figshare.com/articles/journal_contribution/Influence_of_intra-tumoral_heterogeneity_on_the_evaluation_of_BCL2_E-cadherin_EGFR_EMMPRIN_and_Ki-67_expression_in_tissue_microarrays_from_breast_cancer/5666152
10.6084/m9.figshare.5666152